Literature DB >> 11074142

Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies.

A Leminen1, M Forss, J Paavonen.   

Abstract

OBJECTIVE: To evaluate complications after different vulvectomies performed because of vulvar cancer. STUDY
DESIGN: Retrospective analysis of 149 patients who underwent vulvectomy.
RESULTS: Wound infections was found in 58%. Overweight, central or bilateral location of the tumor, and non-radical surgery were significant predictors of wound infections. Patients with a wound infection had more often wound breakdown (P<0.001), prolonged healing time (P<0.000), and lymphedema (P<0.001) than patients without infection. Antimicrobial prophylaxis did not prevent wound infection. Wound infections were found in 75% after radical en bloc vulvectomy (RV) and in 47% after modified vulvectomies (MV) (P<0.001). Also wound breakdown (47 versus 20%) (P<0.001) and lymphedema (48 versus 12%) (P<0.0001) were more common in RV group than in MV group. Lymphocysts were found in 7%, and showed no association with wound infection or type of operation. The mean hospital stay was 26 days in patients with wound infection and 12 days in patients without infection, 31 days in RV group and 12 days in MV group, respectively.
CONCLUSIONS: Wound infections are major determinants for both acute and late complications. Postoperative complications reduce with increasing use of modified vulvectomies.

Entities:  

Mesh:

Year:  2000        PMID: 11074142     DOI: 10.1016/s0301-2115(00)00273-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

Review 1.  Incidence of lower limb lymphedema after vulvar cancer: A systematic review and meta-analysis.

Authors:  Jiuzuo Huang; Nanze Yu; Xiaojun Wang; Xiao Long
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 2.  Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement.

Authors:  Alpaslan Kaban; Işık Kaban; Selim Afşar
Journal:  Gynecol Oncol Rep       Date:  2017-02-10

3.  Secondary healing strategy for difficult wound closure in invasive vulvar cancer: a pilot case-control study.

Authors:  Altamiro Ribeiro Dias-Jr; José Maria Soares-Jr; Maria Beatriz Sartor de Faria; Maria Luiza Noqueira Dias Genta; Jesus Paula Carvalho; Edmund C Baracat
Journal:  Clinics (Sao Paulo)       Date:  2019-09-02       Impact factor: 2.365

4.  Case Report: Biologic graft placement with subsequent radiation therapy following radical vulvectomy for adenoid cystic carcinoma of the Bartholin's gland.

Authors:  Keely Ulmer; Megan E McDonald; Joseph T Kowalski
Journal:  Gynecol Oncol Rep       Date:  2021-02-27

5.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

Review 6.  Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.

Authors:  Pavol Zubor; Yun Wang; Alena Liskova; Marek Samec; Lenka Koklesova; Zuzana Dankova; Anne Dørum; Karol Kajo; Dana Dvorska; Vincent Lucansky; Bibiana Malicherova; Ivana Kasubova; Jan Bujnak; Milos Mlyncek; Carlos Alberto Dussan; Peter Kubatka; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.